HCP Connect Contributor
Dr. Rohan Gupta
Dr. Rohan Gupta contributes dermatology drug update coverage for HCP Connect, with emphasis on source-verified therapeutic developments and practical clinical context for US-licensed practitioners. This profile links the author's recent clinical coverage, specialty focus, and professional contributor metadata in one place.
Recent Drug Updates
16 total
Dermatology
Atopic Dermatitis Biologics Comparison: Dupilumab, Tralokinumab, Lebrikizumab, and JAK Inhibitors
Atopic dermatitis biologics comparison: dupilumab, tralokinumab, lebrikizumab, and JAK inhibitors for effective treatment.
Dermatology
Deucravacitinib and Tapinarof: New Oral Options for Plaque Psoriasis Treatment
Deucravacitinib and tapinarof provide new oral options for plaque psoriasis treatment, enhancing management strategies for clinicians.
Dermatology
Dupilumab vs Tralokinumab vs Lebrikizumab vs Difamilast: Biologics Comparison for Atopic Dermatitis in 2025
Comparative analysis of dupilumab, tralokinumab, lebrikizumab, and difamilast for atopic dermatitis reveals key efficacy and safety insights.
Dermatology
FDA Approves Difamilast for Atopic Dermatitis: Expanding Options for Pediatric and Adult Patients
FDA approves difamilast for atopic dermatitis: a new topical PDE4 inhibitor expanding treatment options for pediatric and adult patients.
Dermatology
FDA Approves Dupilumab for Atopic Dermatitis: Key Comparisons with Tralokinumab, Lebrikizumab, and Difamilast
Dupilumab approved for atopic dermatitis: key comparisons with tralokinumab, lebrikizumab, and difamilast.
Dermatology
IL-17 vs IL-23 vs TNF Inhibitors: 2025 Comparison for Plaque Psoriasis Treatment
IL-17 inhibitors show superior efficacy in plaque psoriasis treatment compared to IL-23 inhibitors, impacting clinical decisions in 2025.
Dermatology
FDA Approves Icotrokinra for Plaque Psoriasis: First Oral IL-23 Antagonist
FDA approves icotrokinra for plaque psoriasis: first oral IL-23 receptor antagonist offering significant efficacy in treatment.
Medical Devices
Boost Precision Health with Top Biomarker Tests
Discover how leading biomarker testing companies can enhance patient outcomes, streamline drug development, and optimize treatment plans with cutting-edge diagnostics and real-worl...
Pharmaceutical
AI Models Boost Diagnostic Accuracy
Discover how foundation models in medtech improve diagnostic accuracy and streamline clinical workflows for healthcare professionals.
Digital Health
Automate Workflows 30% Faster with AI
Discover how AI can accelerate life sciences research, uncover novel insights, and boost decision confidence with automated workflows and transparent analysis.
Medical Research
New Target to Lower Glucose, Lipid Levels in Obesity
Discover a conserved lncRNA motif that reduces glucose and lipid levels in obese mice, offering a potential therapeutic target for metabolic disease treatment.
Medical Research
Identify Mesothelial Cell States Across 12 Organs
Discover a comprehensive mesothelial cell compendium across 12 mouse organs, revealing insights into fibrosis and cell differentiation for improved disease understanding.
Medical Research
Uncover Inhibitory Synapse Secrets
Discover the molecular basis of inhibitory postsynaptic densities and its implications for neurological research and treatment approaches in neurology and psychiatry.
Medical Research
New Hope for Noonan Syndrome Heart Defects
Researchers identify genetic drivers of Noonan syndrome heart defects and discover a potential therapeutic, offering new treatment options for this rare genetic disorder.
Digital Health
Automate 80% of Prior Auth Workflow
Streamline prior authorization with AI-powered automation, reducing denials by up to 75% and increasing efficiency for therapy clinics.
Medical Opinion
Reduce Burnout by 30% with Mindful Self-Care
Discover how mindfulness and self-compassion can help physicians heal from medical training and reduce burnout, improving overall well-being and leadership.